시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 기침약 시장 규모, 점유율 및 동향 분석 보고서 : 연령별, 유통 채널별, 유형별, 투여량별, 지역별 전망 및 예측(2023-2030년)
Global Cough Remedies Market Size, Share & Trends Analysis Report By Age (Adult and Pediatric), By Distribution Channel (Retail Pharmacy, Hospital and Online Pharmacies), By Type, By Dosage. By Regional Outlook and Forecast, 2023 - 2030
상품코드 : 1461687
리서치사 : KBV Research
발행일 : 2024년 03월
페이지 정보 : 영문 266 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,600 ￦ 4,939,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,320 ￦ 5,927,000
PDF (Multi User License) help
PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,048 ￦ 8,298,000
PDF (Corporate User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계 기침약 시장 규모는 예측 기간 동안 5.3%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 128억 달러에 달할 것으로 예상됩니다.

또한, 제조업체들은 더 나은 치료 효과를 가진 기침약을 개발하기 위해 연구개발에 투자하고 있습니다. 여기에는 기침 증상을보다 효과적으로 억제하기 위해 새로운 활성 성분, 시너지 효과가있는 조합 및 고급 약물 전달 시스템의 도입이 포함됩니다. 따라서 이러한 요인들은 향후 몇 년동안 기침약에 대한 수요를 촉진할 수 있습니다.

그러나 규제 당국은 주로 소비자의 안전을 보호하고 제품의 효능을 보장하기 위해 기침약의 처방, 라벨링 및 마케팅을 규제하는 엄격한 지침을 부과하고 있습니다. 이러한 표준을 준수하려면 제조업체는 엄격한 테스트, 면밀한 문서화 및 긴 승인 프로세스를 거쳐야하므로 비용이 크게 증가하고 시장 출시 시간이 지연됩니다. 따라서 이러한 요인들은 향후 몇 년동안 기침약에 대한 수요를 감소시킬 수 있습니다.

또한, 팬데믹으로 인해 호흡기 감염을 예방하는 데 있어 면역 건강의 중요성이 강조되면서 소비자들은 건강 관리에 있어 면역력 강화 제품을 우선순위에 두게 되었습니다. 제조업체는 면역력 강화 보조제를 포함한 제품 라인을 확장하거나 기침약에 면역력 강화 성분을 포함시킴으로써 이러한 추세를 활용할 수 있습니다. 이처럼 코로나19 팬데믹은 시장에 긍정적인 영향을 미쳤습니다.

목차

제1장 시장 범위와 조사 방법

제2장 시장 요람

제3장 시장 개요

제4장 세계 시장 : 연령별

제5장 세계 시장 : 유통 채널별

제6장 세계 시장 : 유형별

제7장 세계 시장 : 투여별

제8장 세계 시장 : 지역별

제9장 기업 개요

제10장 기침약 시장을 위한 성공 필수 조건

LSH
영문 목차

영문목차

The Global Cough Remedies Market size is expected to reach $12.8 billion by 2030, rising at a market growth of 5.3% CAGR during the forecast period.

Without requiring a prescription, pharmacies, supermarkets, and online marketplaces provide convenient access to a vast selection of over-the-counter cough remedies. Consequently, the online pharmacies segment by distribution channel would generate approximately 19.4% revenue share of the market by 2030. Consumers appreciate the convenience and flexibility of purchasing cough medications from these accessible channels, eliminating the hassle of visiting a healthcare provider for minor ailments.

Rapid industrialization, urbanization, and vehicular emissions worsen air quality in many regions globally. Exposure to pollutants like particulate matter, sulfur dioxide, nitrogen oxides, and volatile organic compounds irritates the respiratory tract, leading to coughing, wheezing, and other respiratory symptoms. As air pollution levels rise, so does the incidence of respiratory diseases, necessitating effective cough remedies to manage associated symptoms. Hence, these aspects can assist in the growth of the market.

Additionally, Manufacturers invest in research and development to formulate cough remedies with enhanced therapeutic effects. This includes incorporating novel active ingredients, synergistic combinations, and advanced drug delivery systems to target cough symptoms more effectively. Hence, these factors can fuel the demand for cough remedies in the upcoming years.

However, Regulatory bodies impose stringent guidelines governing cough remedies' formulation, labeling, and marketing, primarily safeguarding consumer safety and ensuring product efficacy. Compliance with these standards requires manufacturers to undergo rigorous testing, meticulous documentation, and lengthy approval processes, substantially increasing costs and delaying time-to-market. Hence, these factors can lead to a decreased demand for cough remedies in the upcoming years.

Furthermore, the pandemic has underscored the importance of immune health in preventing respiratory infections, leading consumers to prioritize immune-supportive products in their wellness regimens. By expanding their product lines to include immune-support supplements or incorporating immune-boosting constituents into cough remedies, manufacturers may be able to capitalize on this trend. Thus, the COVID-19 pandemic positively impacted the market.

By Age Analysis

By age, the market is bifurcated into pediatric and adult. In 2022, the pediatric segment witnessed a 27.35% revenue share in the market. Pediatric cough remedies are formulated with ingredients and dosages deemed safe and effective for children, considering their unique physiological characteristics and susceptibility to adverse effects. Manufacturers must adhere to stringent regulatory guidelines governing pediatric medications to ensure product safety and efficacy. Thus, these factors can pose lucrative growth prospects for the market.

By Distribution Channel Analysis

Based on distribution channel, the market is segmented into retail pharmacy, hospital, and online pharmacies. The retail pharmacy segment held a 52.64% revenue share in the market in 2022. Retail pharmacies serve as accessible points of contact for consumers seeking cough remedies. Their widespread presence in local communities ensures convenience and ease of access, allowing consumers to quickly obtain over-the-counter cough medications without needing a prescription. Therefore, owing to these factors, the segment will expand rapidly in the upcoming years.

By Type Analysis

Based on type, the market is segmented into expectorants, antihistamines, bronchodilators, antibiotics, and others. In 2022, the antihistamines segment garnered a 32.75% revenue share in the market. Antihistamines are frequently prescribed to treat allergic reactions, including sinusitis, allergic rhinitis, and hay fever, which induce coughing. By blocking the effects of histamine, antihistamines help relieve nasal congestion, sneezing, and itching, which often accompany allergic cough. Therefore, these aspects can lead to enhanced demand in the segment.

By Dosage Analysis

On the basis of dosage form, the market is divided into oral syrup, tablets & pills, lozenges, and others. The oral syrup segment recorded a 39.3% revenue share in the remedies market in 2022. Oral syrups come in various formulations, allowing manufacturers to tailor products to specific cough types and symptoms. Antitussive syrups are designed to suppress cough reflexes, providing relief from dry, non-productive coughs, while expectorant syrups help loosen and expel mucus from the respiratory tract, easing productive coughs. Therefore, these factors can help in the growth of the segment.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Asia Pacific segment acquired a 22.9% revenue share in the market. The Asia Pacific region is home to a significant portion of the world's population, with densely populated countries such as China and India driving demand for healthcare products, including cough remedies. Rapid urbanization and rising disposable incomes in emerging economies contribute to increased access to healthcare and a growing demand for over-the-counter remedies. Hence, the segment will expand rapidly in the upcoming years.

List of Key Companies Profiled

Global Cough Remedies Market Report Segmentation

By Age

By Distribution Channel

By Type

By Dosage

By Geography

Table of Contents

Chapter 1.Market Scope & Methodology

Chapter 2.Market at a Glance

Chapter 3.Market Overview

Chapter 4.Global Cough Remedies Market by Age

Chapter 5.Global Cough Remedies Market by Distribution Channel

Chapter 6.Global Cough Remedies Market by Type

Chapter 7.Global Cough Remedies Market by Dosage

Chapter 8.Global Cough Remedies Market by Region

Chapter 9.Company Profiles

Chapter 10.Winning Imperatives of Cough Remedies Market

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기